Literature DB >> 915485

Age-dependent and strain-related differences of virulence of Semliki Forest virus in mice.

P Fleming.   

Abstract

Factors that influence the virulence of Semliki Forest virus for mice have been studied. In vivo experiments showed that maximum brain infectivities following i.p. inoculation of adult mice with a virus strain of low virulence were less than those found in mice showing clinical signs in virulent infections. The virulent strains generally caused death before antibody could be detected in brain tissue; the less virulent strain caused an infection that was neuroinvasive, but infectivity increased less rapidly in the brain and allowed antibody to intervene before clinical signs were apparent. IgG3 antibody was first detected in brain tissue coincident with the beginning of the decline of brain infectivities in avirulent infections; other sub-classes of IgG antibody were not detected until later. In vitro experiments showed differences in abilities of SFV strains to replicate in tissue culture and adult mouse brain tissue, and differences in susceptibility to infection of brain tissue from mice of various ages. These in vitro results could provide a basis for differences of virulence.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915485     DOI: 10.1099/0022-1317-37-1-93

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

2.  Neurogenic spread of Semliki Forest virus in mice.

Authors:  G Kaluza; G Lell; M Reinacher; L Stitz; W R Willems
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.

Authors:  W A Boere; M Harmsen; C A Kraaijeveld; H Snippe
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Delayed-type hypersensitivity against Semliki Forest virus in mice.

Authors:  C A Kraaijeveld; M Harmsen; B Khader Boutahar-Trouw
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

5.  A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus.

Authors:  John K Fazakerley; Amanda Boyd; Marja L Mikkola; Leevi Kääriäinen
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation.

Authors:  J K Fazakerley; H E Webb
Journal:  Br J Exp Pathol       Date:  1987-02

7.  Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections.

Authors:  H P Hefti; M Frese; H Landis; C Di Paolo; A Aguzzi; O Haller; J Pavlovic
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.

Authors:  A J Suckling; S Jagelman; H E Webb
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

9.  Semliki forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells.

Authors:  G J Atkins; B J Sheahan
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  Brain viral persistence and myelin damage in nude mice.

Authors:  M Chew-Lim
Journal:  Can J Comp Med       Date:  1979-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.